Location History:
- 83624 Otterfing, DE (2005)
- Otterfing, DE (2008 - 2018)
Company Filing History:
Years Active: 2005-2018
Title: **Nadia Harbeck: Innovator in Cancer Treatment Prediction**
Introduction
Nadia Harbeck is a prominent inventor based in Otterfing, Germany. With a remarkable track record of six patents, she has made significant strides in the field of oncology, particularly in predicting treatment outcomes for patients undergoing anthracycline therapy.
Latest Patents
Harbeck’s latest innovations focus on improving patient care through predictive methodologies. One of her notable patents is for "Markers for the prediction of outcome of anthracycline treatment." This invention involves methods for anticipating the efficacy of anthracycline treatment in patients with cell proliferative disorders by analyzing the expression levels of specific genes such as PITX2, TFF1, and PLAU. Additionally, she has developed patents pertaining to "Methods for the prognosis of breast cancer," which utilize modified genomic sequences and oligonucleotides to detect the methylation state of DNA, thereby aiding in the prediction of disease-free survival and treatment responsiveness for patients with breast tissue disorders.
Career Highlights
Throughout her career, Nadia Harbeck has been affiliated with notable companies, including Epigenomics AG. Her work has been instrumental in advancing the understanding of genetic factors in cancer treatment outcomes, making her a vital contributor to current medical research.
Collaborations
Harbeck has collaborated with esteemed professionals such as Manfred Schmitt and Ronald Kates. These partnerships have further enriched her research endeavors, leading to groundbreaking inventions that have the potential to enhance patient treatment protocols and outcomes significantly.
Conclusion
Nadia Harbeck exemplifies the spirit of innovation in the medical field. Her continuous contributions through patents and collaborations not only advance cancer treatment methodologies but also pave the way for future research in predictive medicine. Her work serves as an inspiration for aspiring inventors and researchers seeking to make a difference in healthcare.